These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19888505)

  • 41. Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.
    Bergstra SA; Allaart CF; van den Berg R; Chopra A; Govind N; Huizinga TWJ; Landewe RBM
    Arthritis Res Ther; 2017 Nov; 19(1):258. PubMed ID: 29166919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis.
    Hodkinson B; Musenge E; Ally M; Meyer PW; Anderson R; Tikly M
    Scand J Rheumatol; 2012 Oct; 41(5):366-74. PubMed ID: 22803639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva).
    Ceccarelli F; Perricone C; Trotta F; Cuomo G; Pellerito R; Bagnato G; Salaffi F; Caporali R; Cutolo M; Galeazzi M; Fiocco U; Lapadula G; Bombardieri S; Bianchi G; Gorla R; Giardina AR; Gallo G; Giardino AM; Valesini G;
    Clin Exp Rheumatol; 2013; 31(3):341-9. PubMed ID: 23380023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
    Gibofsky A; Cannon GW; Harrison DJ; Joseph GJ; Bitman B; Chaudhari S; Collier DH
    Clin Exp Rheumatol; 2015; 33(3):297-301. PubMed ID: 25738333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
    Westhoff G; Schneider M; Raspe H; Zeidler H; Runge C; Volmer T; Zink A
    Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.
    Tiippana-Kinnunen T; Paimela L; Kautiainen H; Laasonen L; Leirisalo-Repo M
    Scand J Rheumatol; 2010; 39(1):12-8. PubMed ID: 20132065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
    Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.
    Symmons D; Tricker K; Roberts C; Davies L; Dawes P; Scott DL
    Health Technol Assess; 2005 Sep; 9(34):iii-iv, ix-x, 1-78. PubMed ID: 16153351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Summary of the practice guideline 'Rheumatoid arthritis' (first revision) from the Dutch College of General Practitioners].
    Wiersma T; Flikweert S; van den Bosch WJ;
    Ned Tijdschr Geneeskd; 2004 Mar; 148(12):559-64. PubMed ID: 15074177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying factors hampering physical activity in longstanding rheumatoid arthritis: what is the role of glucocorticoid therapy?
    van der Goes MC; Hoes JN; Cramer MJ; van der Veen MJ; van der Werf JH; Bijlsma JW; Jacobs JW
    Clin Exp Rheumatol; 2014; 32(2):155-61. PubMed ID: 24480192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria.
    Gruppo Italiano Artrite Reumatoide Aggressiva Registry Study Group
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S129-32. PubMed ID: 14969064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20.
    Albert DA; Huang G; Dubrow G; Brensinger CM; Berlin JA; Williams HJ
    J Rheumatol; 2004 May; 31(5):856-66. PubMed ID: 15124243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical presentation, burden of disease and treatment in young-onset and late-onset rheumatoid arthritis: a matched-pairs analysis taking age and disease duration into account.
    Huscher D; Sengler C; Gromnica-Ihle E; Bischoff S; Eidner T; Ochs W; Richter J; Zink A
    Clin Exp Rheumatol; 2013; 31(2):256-62. PubMed ID: 23305590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rheumatoid arthritis disease activity and disability affect the risk of serious infection events in RADIUS 1.
    Weaver A; Troum O; Hooper M; Koenig AS; Chaudhari S; Feng J; Wenkert D
    J Rheumatol; 2013 Aug; 40(8):1275-81. PubMed ID: 23772079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association.
    Katchamart W; Narongroeknawin P; Chevaisrakul P; Dechanuwong P; Mahakkanukrauh A; Kasitanon N; Pakchotanon R; Sumethkul K; Ueareewongsa P; Ukritchon S; Bhurihirun T; Duangkum K; Intapiboon P; Intongkam S; Jangsombatsiri W; Jatuworapruk K; Kositpesat N; Leungroongroj P; Lomarat W; Petcharat C; Sittivutworapant S; Suebmee P; Tantayakom P; Tipsing W; Asavatanabodee P; Chiowchanwisawakit P; Foocharoen C; Koolvisoot A; Louthrenoo W; Siripaitoon B; Totemchokchyakarn K; Kitumnuaypong T;
    Int J Rheum Dis; 2017 Sep; 20(9):1142-1165. PubMed ID: 27452207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
    Mueller RB; Reshiti N; Kaegi T; Finckh A; Haile SR; Schulze-Koops H; Schiff M; Spaeth M; von Kempis J;
    Clin Rheumatol; 2017 Jan; 36(1):59-66. PubMed ID: 27838788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treat-to-target approach in daily clinical practice in Pakistani patients with early Rheumatoid Arthritis.
    Farman S; Ahmad NM; Saeed MA; Asad K; Shabbir G
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):129-33. PubMed ID: 25703758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for "near remission" of DAS or single measures.
    Pincus T; Sokka T; Kavanaugh A
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S50-6. PubMed ID: 15552515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the management of rheumatoid arthritis.
    Dale J
    Scott Med J; 2015 Aug; 60(3):108-14. PubMed ID: 26122283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.